Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

NCT01057147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca
Dry Eye

Interventions

DRUG: rebamipide 2% ophthalmic suspension
DRUG: placebo eye drops

Sponsor

Kubota Vision Inc.

Collaborators

[object Object]